-
EP3912464
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3912464
| EP3912464 - HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 27.05.2022 Database last updated on 02.08.2024 | |
| Former | The application has been published Status updated on 22.10.2021 | Most recent event Tooltip | 20.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, NY 10591 / US | [2021/47] | Inventor(s) | 01 /
MACDONALD, Lynn White Plains NY, 10605 / US | 02 /
MCWHIRTHER, John Tarrytown NY, 10591 / US | 03 /
TU, Naxin Tarrytown NY, 10591 / US | 04 /
STEVENS, Sean Del Mar CA, 92014 / US | 05 /
MURPHY, Andrew J Croton-on-Hudson NY, 10520 / US | [2021/47] | Representative(s) | J A Kemp LLP 80 Turnmill Street London EC1M 5QU / GB | [2021/47] | Application number, filing date | 21167679.6 | 07.03.2013 | [2021/47] | Priority number, date | US201261658466P | 12.06.2012 Original published format: US 201261658466 P | US201261663131P | 22.06.2012 Original published format: US 201261663131 P | [2021/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3912464 | Date: | 24.11.2021 | Language: | EN | [2021/47] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 21.10.2021 | Classification | IPC: | A01K67/027, C07K16/28, C07K16/40, C07K16/46 | [2021/47] | CPC: |
A01K67/0278 (EP,CN,KR,RU,US);
A01K67/0276 (US);
C07K16/18 (KR);
C07K16/461 (EP,CN,RU,US);
C12N15/8509 (KR);
C12N9/6489 (KR);
C12P21/02 (US);
A01K2207/15 (KR,US);
A01K2217/072 (KR,US);
A01K2217/075 (US);
A01K2217/15 (KR,US);
A01K2227/105 (KR,US);
A01K2267/0387 (KR);
C07K2319/00 (KR);
C12N2800/204 (KR);
C12N2800/30 (KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/26] |
| Former [2021/47] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | HUMANISIERTE NICHTMENSCHLICHE TIERE MIT EINGESCHRÄNKTEN SCHWERKETTIGEN IMMUNGLOBULIN-LOCI | [2021/47] | English: | HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI | [2021/47] | French: | ANIMAUX NON HUMAINS HUMANISÉS À LOCUS LIMITÉS DE CHAÎNE LOURDE D'IMMUNOGLOBULINE | [2021/47] | Examination procedure | 20.05.2022 | Examination requested [2022/26] | 20.05.2022 | Date on which the examining division has become responsible | 17.06.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time | 26.08.2022 | Amendment by applicant (claims and/or description) | Parent application(s) Tooltip | EP13710268.7 / EP2858487 | EP19190845.8 / EP3597037 | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report | 26.08.2022 | Request for further processing filed | 26.08.2022 | Full payment received (date of receipt of payment) Request granted | 01.09.2022 | Decision despatched | Fees paid | Renewal fee | 09.04.2021 | Renewal fee patent year 03 | 09.04.2021 | Renewal fee patent year 04 | 09.04.2021 | Renewal fee patent year 05 | 09.04.2021 | Renewal fee patent year 06 | 09.04.2021 | Renewal fee patent year 07 | 09.04.2021 | Renewal fee patent year 08 | 09.04.2021 | Renewal fee patent year 09 | 23.03.2022 | Renewal fee patent year 10 | 21.03.2023 | Renewal fee patent year 11 | 20.03.2024 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2009097006 (MEDAREX INC [US], et al); | [A]US2012021409 (MCWHIRTER JOHN [US], et al); | [AP]US2012167237 (BRADLEY ALLAN [GB], et al); | [AP]WO2012141798 (REGENERON PHARMA [US], et al); | [AP]WO2013022782 (REGENERON PHARMA [US], et al); | [T]US2013096287 (MACDONALD LYNN [US], et al); | by applicant | US6586251 | US6596541 | US7105348 | US7294754 | US7473557 | US7576259 | US7659842 |